nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR2A—phrenic nerve—thymus cancer	0.0969	0.242	CbGeAlD
Lurasidone—HTR7—pulmonary artery—thymus cancer	0.0564	0.141	CbGeAlD
Lurasidone—HTR7—vein—thymus cancer	0.0513	0.128	CbGeAlD
Lurasidone—HTR2A—pulmonary artery—thymus cancer	0.0352	0.0878	CbGeAlD
Lurasidone—HTR2A—vein—thymus cancer	0.032	0.0799	CbGeAlD
Lurasidone—Creatine phosphokinase increased—Octreotide—thymus cancer	0.032	0.0534	CcSEcCtD
Lurasidone—Pregnancy—Octreotide—thymus cancer	0.0296	0.0494	CcSEcCtD
Lurasidone—Galactorrhoea—Octreotide—thymus cancer	0.0259	0.0433	CcSEcCtD
Lurasidone—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0244	0.0408	CcSEcCtD
Lurasidone—Breast pain—Octreotide—thymus cancer	0.0193	0.0322	CcSEcCtD
Lurasidone—Amenorrhoea—Octreotide—thymus cancer	0.0191	0.0319	CcSEcCtD
Lurasidone—Sleep disorder—Octreotide—thymus cancer	0.0141	0.0235	CcSEcCtD
Lurasidone—Diabetes mellitus—Octreotide—thymus cancer	0.014	0.0234	CcSEcCtD
Lurasidone—Hot flush—Octreotide—thymus cancer	0.013	0.0218	CcSEcCtD
Lurasidone—Menopausal symptoms—Octreotide—thymus cancer	0.0129	0.0216	CcSEcCtD
Lurasidone—Osteoarthritis—Octreotide—thymus cancer	0.0122	0.0204	CcSEcCtD
Lurasidone—Psychotic disorder—Octreotide—thymus cancer	0.0119	0.0199	CcSEcCtD
Lurasidone—HTR7—neck—thymus cancer	0.0116	0.0291	CbGeAlD
Lurasidone—Abdominal pain upper—Octreotide—thymus cancer	0.0111	0.0186	CcSEcCtD
Lurasidone—Nasopharyngitis—Octreotide—thymus cancer	0.0109	0.0182	CcSEcCtD
Lurasidone—Gastritis—Octreotide—thymus cancer	0.0108	0.018	CcSEcCtD
Lurasidone—Influenza—Octreotide—thymus cancer	0.0105	0.0176	CcSEcCtD
Lurasidone—Abdominal discomfort—Octreotide—thymus cancer	0.0101	0.0169	CcSEcCtD
Lurasidone—Dysuria—Octreotide—thymus cancer	0.00987	0.0165	CcSEcCtD
Lurasidone—Weight increased—Octreotide—thymus cancer	0.0096	0.016	CcSEcCtD
Lurasidone—Hyperglycaemia—Octreotide—thymus cancer	0.00952	0.0159	CcSEcCtD
Lurasidone—Urinary tract infection—Octreotide—thymus cancer	0.00914	0.0153	CcSEcCtD
Lurasidone—HTR1A—hematopoietic system—thymus cancer	0.00907	0.0226	CbGeAlD
Lurasidone—Hepatobiliary disease—Octreotide—thymus cancer	0.0089	0.0148	CcSEcCtD
Lurasidone—HTR7—hematopoietic system—thymus cancer	0.00867	0.0216	CbGeAlD
Lurasidone—Bradycardia—Octreotide—thymus cancer	0.0086	0.0143	CcSEcCtD
Lurasidone—HTR7—epithelium—thymus cancer	0.00793	0.0198	CbGeAlD
Lurasidone—Cardiac disorder—Octreotide—thymus cancer	0.00784	0.0131	CcSEcCtD
Lurasidone—Arrhythmia—Octreotide—thymus cancer	0.00754	0.0126	CcSEcCtD
Lurasidone—Mental disorder—Octreotide—thymus cancer	0.0074	0.0123	CcSEcCtD
Lurasidone—Malnutrition—Octreotide—thymus cancer	0.00735	0.0123	CcSEcCtD
Lurasidone—HTR2A—neck—thymus cancer	0.00726	0.0181	CbGeAlD
Lurasidone—Flatulence—Octreotide—thymus cancer	0.00724	0.0121	CcSEcCtD
Lurasidone—Back pain—Octreotide—thymus cancer	0.00711	0.0119	CcSEcCtD
Lurasidone—Muscle spasms—Octreotide—thymus cancer	0.00707	0.0118	CcSEcCtD
Lurasidone—Vision blurred—Octreotide—thymus cancer	0.00693	0.0116	CcSEcCtD
Lurasidone—Tremor—Octreotide—thymus cancer	0.00689	0.0115	CcSEcCtD
Lurasidone—Anaemia—Octreotide—thymus cancer	0.00679	0.0113	CcSEcCtD
Lurasidone—Agitation—Octreotide—thymus cancer	0.00676	0.0113	CcSEcCtD
Lurasidone—Malaise—Octreotide—thymus cancer	0.00663	0.0111	CcSEcCtD
Lurasidone—Vertigo—Octreotide—thymus cancer	0.0066	0.011	CcSEcCtD
Lurasidone—Syncope—Octreotide—thymus cancer	0.00659	0.011	CcSEcCtD
Lurasidone—Loss of consciousness—Octreotide—thymus cancer	0.00646	0.0108	CcSEcCtD
Lurasidone—Convulsion—Octreotide—thymus cancer	0.00637	0.0106	CcSEcCtD
Lurasidone—ADRA2A—hematopoietic system—thymus cancer	0.00636	0.0159	CbGeAlD
Lurasidone—Hypertension—Octreotide—thymus cancer	0.00635	0.0106	CcSEcCtD
Lurasidone—Myalgia—Octreotide—thymus cancer	0.00626	0.0104	CcSEcCtD
Lurasidone—Anxiety—Octreotide—thymus cancer	0.00624	0.0104	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00622	0.0104	CcSEcCtD
Lurasidone—Dry mouth—Octreotide—thymus cancer	0.00612	0.0102	CcSEcCtD
Lurasidone—DRD2—pituitary gland—thymus cancer	0.00608	0.0152	CbGeAlD
Lurasidone—ADRA2C—cardiac atrium—thymus cancer	0.00605	0.0151	CbGeAlD
Lurasidone—Infection—Octreotide—thymus cancer	0.00596	0.00994	CcSEcCtD
Lurasidone—ADRA2C—pituitary gland—thymus cancer	0.00591	0.0148	CbGeAlD
Lurasidone—Shock—Octreotide—thymus cancer	0.0059	0.00985	CcSEcCtD
Lurasidone—Nervous system disorder—Octreotide—thymus cancer	0.00588	0.00982	CcSEcCtD
Lurasidone—Tachycardia—Octreotide—thymus cancer	0.00586	0.00977	CcSEcCtD
Lurasidone—Skin disorder—Octreotide—thymus cancer	0.00583	0.00972	CcSEcCtD
Lurasidone—Hyperhidrosis—Octreotide—thymus cancer	0.0058	0.00968	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00547	0.00912	CcSEcCtD
Lurasidone—Insomnia—Octreotide—thymus cancer	0.00543	0.00905	CcSEcCtD
Lurasidone—HTR2A—hematopoietic system—thymus cancer	0.00541	0.0135	CbGeAlD
Lurasidone—Dyspnoea—Octreotide—thymus cancer	0.00535	0.00892	CcSEcCtD
Lurasidone—Somnolence—Octreotide—thymus cancer	0.00533	0.0089	CcSEcCtD
Lurasidone—Dyspepsia—Octreotide—thymus cancer	0.00528	0.00881	CcSEcCtD
Lurasidone—Decreased appetite—Octreotide—thymus cancer	0.00522	0.0087	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Octreotide—thymus cancer	0.00518	0.00864	CcSEcCtD
Lurasidone—Fatigue—Octreotide—thymus cancer	0.00517	0.00863	CcSEcCtD
Lurasidone—HTR7—lung—thymus cancer	0.00504	0.0126	CbGeAlD
Lurasidone—CYP3A4—hematopoietic system—thymus cancer	0.00501	0.0125	CbGeAlD
Lurasidone—HTR2A—epithelium—thymus cancer	0.00494	0.0123	CbGeAlD
Lurasidone—Gastrointestinal pain—Octreotide—thymus cancer	0.00491	0.00819	CcSEcCtD
Lurasidone—ADRA2A—cardiac atrium—thymus cancer	0.00483	0.0121	CbGeAlD
Lurasidone—DRD2—lung—thymus cancer	0.00476	0.0119	CbGeAlD
Lurasidone—Abdominal pain—Octreotide—thymus cancer	0.00474	0.00791	CcSEcCtD
Lurasidone—ADRA2A—pituitary gland—thymus cancer	0.00472	0.0118	CbGeAlD
Lurasidone—ADRA2C—lung—thymus cancer	0.00463	0.0116	CbGeAlD
Lurasidone—Asthenia—Octreotide—thymus cancer	0.0043	0.00718	CcSEcCtD
Lurasidone—Pruritus—Octreotide—thymus cancer	0.00424	0.00708	CcSEcCtD
Lurasidone—Diarrhoea—Octreotide—thymus cancer	0.0041	0.00685	CcSEcCtD
Lurasidone—ADRA2A—thyroid gland—thymus cancer	0.00407	0.0102	CbGeAlD
Lurasidone—HTR2A—pituitary gland—thymus cancer	0.00401	0.01	CbGeAlD
Lurasidone—Dizziness—Octreotide—thymus cancer	0.00397	0.00662	CcSEcCtD
Lurasidone—Vomiting—Octreotide—thymus cancer	0.00381	0.00636	CcSEcCtD
Lurasidone—Rash—Octreotide—thymus cancer	0.00378	0.00631	CcSEcCtD
Lurasidone—Dermatitis—Octreotide—thymus cancer	0.00378	0.00631	CcSEcCtD
Lurasidone—ADRA2A—lung—thymus cancer	0.00369	0.00922	CbGeAlD
Lurasidone—Nausea—Octreotide—thymus cancer	0.00356	0.00595	CcSEcCtD
Lurasidone—ADRA2C—lymph node—thymus cancer	0.00317	0.0079	CbGeAlD
Lurasidone—HTR2A—lung—thymus cancer	0.00314	0.00784	CbGeAlD
Lurasidone—ADRA2A—lymph node—thymus cancer	0.00253	0.00631	CbGeAlD
